Updates from Neuromod and Lenire
Neuromod Newsroom
75% of UK Tinnitus Sufferers Never Receive Treatment
Neuromod Launches Tinnitus Telehealth – Ireland's First
Neuromod Appoints Dr. Jakob Kümmel as Clinical Affairs Manager
Neuromod Closes Series B Financing for Lenire
Science Translational Medicine Publishes Neuromod Research
Rosemarie Tully Named Chief Operating Officer
Neuromod Appoints Florian Elsaesser as COO
Neuromod Supports Tinnitus Week 2020
Neuromod Closes €8 Million Capital Raise
Stay in the Loop
Register for the Neuromod Newsletter to stay up to date on hearing and tinnitus industry news, emerging tinnitus research, and all things Neuromod and Lenire.
Subscribe
